Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

BACKGROUND: The age at which heart failure develops varies widely between countries and drug tolerance and outcomes also vary by age. We have examined the efficacy and safety of LCZ696 according to age in the Prospective comparison of angiotensin receptor neprilysin inhibitor with angiotensin conver...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur Heart J
Main Authors: Jhund, Pardeep S., Fu, Michael, Bayram, Edmundo, Chen, Chen-Huan, Negrusz-Kawecka, Marta, Rosenthal, Arvo, Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J.V., Packer, Milton
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Clinical Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4595742/
https://ncbi.nlm.nih.gov/pubmed/26231885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv330
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares